Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of driver genes and target drugs-related genes in liver cancer based on targeted next generation sequencing.

Neoplasma - 1 Jan 2022

Cui Yunlong, Sun Liwei, Wang Hailong, Zhang Zhenzhen, Dai Hongxia, Liu Pengfei

Abstract excerpt

The purpose of this study was to identify gene mutations, high frequency mutations, and driver genes in liver cancer, and the marketed approved drugs of these genes, to provide evidence for targeted treatment of liver cancer since it is one of the most common cancers worldwide. 34 patients with liver cancer were included, and their blood samples were collected. The pathway enrichment analysis of the mutation gene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to High-Throughput Nucleotide Sequencing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kelch-Like ECH-Associated Protein 1

Share to Liver Neoplasms

Share to Mutation

Share to NF-E2-Related Factor 2

Source

Identifiers

PMID: 34704453
DOI: 10.4149/neo_2021_210902N1258

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of driver genes and target drugs-related genes in liver cancer based on targeted next generation sequencing.PMID 34704453Read ↗

Genome sequencing analysis of liver cancer for precision medicine.Semantic proximity Read ↗

Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapySemantic proximity Read ↗

Targeted sequencing of cancer-associated genes in hepatocellular carcinoma using next generation sequencing.Semantic proximity Read ↗

Genome-wide analysis of genetic variations assisted by Ingenuity Pathway Analysis to comprehensively investigate potential genetic targets associated with the progression of hepatocellular carcinoma.Semantic proximity Read ↗

Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer.Semantic proximity Read ↗

From driver genes to gene families: A computational analysis of oncogenic mutations and ubiquitination anomalies in hepatocellular carcinoma.Semantic proximity Read ↗

Identification of potential crucial genes associated with the pathogenesis and prognosis of liver hepatocellular carcinomaSemantic proximity Read ↗

MAP Kinase and mammalian target of rapamycin are main pathways of gallbladder carcinogenesis: Results from bioinformatic analysis of Next Generation Sequencing data from a hospital-based cohortSemantic proximity Read ↗

Identification of critical genes and biological signaling for metformin treated liver cancerSemantic proximity Read ↗

Comprehensive Analysis of Genomic Mutation Signature and Tumor Mutation Burden for Prognosis of Intrahepatic CholangiocarcinomaSemantic proximity Read ↗

Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysisSemantic proximity Read ↗

Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affecting the survival time of liver cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.